Milestone Pharmaceuticals (MIST) Other financing activities (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Other financing activities of $8.3 million for Q1 2026, up 2798.95% on a QoQ basis from $286000.0 in Q4 2025, and up 5822.14% year-over-year from $140000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Other financing activities (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Other financing activities history runs 9 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- Quarterly Other financing activities rose 5822.14% year-over-year to $8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 11209.21% YoY) and the FY2025 annual result came in at $444000.0, up 737.74% from the prior year.
- Other financing activities was $8.3 million for Q1 2026 at Milestone Pharmaceuticals, up from $286000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $8.3 million in Q1 2026 and bottomed at -$179000.0 in Q4 2022.
- A 5-year average of $658500.0 and a median of $83000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2024 — Other financing activities plunged 563.16% — and 2026, when it surged 5822.14%.
- Milestone Pharmaceuticals' Other financing activities stood at -$179000.0 in 2022, then jumped by 236.87% to $245000.0 in 2023, then sank by 90.2% to $24000.0 in 2024, then jumped by 1091.67% to $286000.0 in 2025, then jumped by 2798.95% to $8.3 million in 2026.
- Business Quant data shows MIST's Other financing activities at $8.3 million in Q1 2026, $286000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.29 Mn |
| Mar 31, 2026 | 8.29 Mn |
| Dec 31, 2025 | 286,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Mar 31, 2024 | 117,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 129,000.00 |
| Mar 31, 2023 | 129,000.00 |